Endoscopy and MRI for restaging early rectal cancer after neoadjuvant treatment
Colorectal Disease2022Vol. 25(2), pp. 211–221
Citations Over TimeTop 21% of 2022 papers
Rutger C. H. Stijns, Jeroen W. A. Leijtens, Eelco de Graaf, Simon P. Bach, Geerard L. Beets, André J. A. Bremers, Regina G. H. Beets‐Tan, Johannes H.W. de Wilt
Abstract
Good and complete responders after chemoradiation of early stage rectal cancer can be best assessed using a multimodality approach combining endoscopy and (DWI-)MRI.
Related Papers
- δ-catenin Expression Correlates with Cell Proliferation in Colorectal Cancer(2013)
- Expression of PTTG and its significance in colorectal cancer(2008)
- → Data from Colorectal Cancer Is Associated with the Presence of Cancer Driver Mutations in Normal Colon(2023)
- → Expression of Galecitn-9 in colorectal cancer and its clinical significance(2023)
- → SLC25A24, a potential and novel biomarker for diagnosing colorectal cancer(2023)